ASUR, USAT, OSIR, CRVL, SYMM, DARA Are Seasonally Ripe To Go Down In the Next Five Weeks
Feb 15, 2013 (M2 PRESSWIRE via COMTEX) --
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Asure Software Inc (NASDAQ:ASUR), USA Technologies Inc (NASDAQ:USAT), Osiris Therapeutics Inc (NASDAQ:OSIR), CorVel Corp (NASDAQ:CRVL), Symmetricom Inc (NASDAQ:SYMM), DARA Biosciences Inc (NASDAQ:DARA) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date
ASUR Asure Software Inc -16.45% 92.31% (12 of 13) Monday, April 1st 2013
USAT USA Technologies Inc -9.02% 92.31% (12 of 13) Wednesday, February 20th 2013
OSIR Osiris Therapeutics Inc -11.15% 100.00% (6 of 6) Tuesday, March 5th 2013
CRVL CorVel Corp -6.98% 84.62% (11 of 13) Friday, March 1st 2013
SYMM Symmetricom Inc -11.93% 84.62% (11 of 13) Tuesday, March 12th 2013
DARA DARA Biosciences Inc -23.56% 84.62% (11 of 13) Monday, April 1st 2013
Asure Software Inc (NASDAQ:ASUR) - Asure Software, Inc. provides on-demand workforce management software and services worldwide. The company s software empowers small to mid-size organizations and divisions of large enterprises to operate efficiently, increase worker productivity, and reduce costs. It offers products that optimize workforce time and attendance tracking, benefits enrollment and tracking, pay stubs and W2 documentation, and meeting and event management. The company provides Netsimplicity, a workspace management solution, which automates the scheduling of a facility, including reserving rooms, requesting equipment, ordering food, sending invitations, and reporting on the meeting environment. Its workforce management product line includes iEmployee, ADI Time, and Legiant, the time and labor management, timesheets, expenses, and accrual management solutions. The company also offers a line of time clocks and mobile applications, which complement the workforce management software product set. In addition, it provides maintenance and support contracts; software patches and upgrades; installation and training; add-on software customization; and professional services. The company serves manufacturing, healthcare, retail, and distribution industries. Asure Software, Inc. sells its products directly, as well as through reseller and referral partners. The company was formerly known as Forgent Networks, Inc. and changed its name to Asure Software, Inc. in December 2009. Asure Software, Inc. was founded in 1985 and is headquartered in Austin, Texas with additional offices in Warwick, Rhode Island, Vancouver, and British Columbia, as well as in Mumbai, India..
USA Technologies Inc (NASDAQ:USAT) - USA Technologies, Inc. provides wireless networking, cashless transactions, asset monitoring, and other value-added services principally to the small ticket unattended retail markets in the United States and internationally. The company principally provides ePort Connect, a service that facilitates electronic payment options, as well as telemetry and machine-to-machine (M2M) services to monitor, control, and report on the results of distributed assets containing electronic payment solutions. Its ePort Connect solution offers POS options, card processing, wireless connectivity, online sales reporting, M2M telemetry and DEX data transfer, over-the-air update, deployment planning, customer support, and value-added services. The company's turnkey solution also includes ePort, a device that is used in self-service and unattended markets comprising vending, and kiosk, as well as facilitates cashless payments by capturing payment information and transmitting it to its network for authorization with the payment system. ePort G series is NFC ready, while ePort Edge provides for magnetic swipe-only cashless payment. Its software versions include ePort SDK, ePort QuickConnect, and eSuds, a solution for the commercial laundry industry that enables laundry operators to provide customers cashless transactions via credit cards, debit cards, and other payment mediums, such as student IDs. Further, it manufactures and sells energy management products comprising VendingMiser and CoolerMiser, which reduce the electrical power consumption of equipment, such as refrigerated vending machines and glass front coolers. USA Technologies, Inc. was founded in 1992 and is based in Malvern, Pennsylvania..
Osiris Therapeutics Inc (NASDAQ:OSIR) - Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, cardiovascular, orthopedic, and wound healing markets. It operates in two segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment focuses on the development, manufacture, and distribution of biologic products for wound healing and use in surgical procedures by harnessing the ability of cells and novel constructs to promote the body's natural healing. This segment s marketed products comprise Grafix and Ovation for tissue repair. The company s lead biologic drug candidate is Prochymal, which is in Phase 2 and Phase 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidate also includes Chondrogen, a preparation of adult mesenchymal stem cells that is in Phase 2 clinical trials for osteoarthritis in the knee and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland..
CorVel Corp (NASDAQ:CRVL) - CorVel Corporation provides medical cost containment and managed care services to manage the medical costs of worker s compensation and auto claims in the United States. The company offers network solutions, including bill review, PPO management, professional review, reimbursement, pharmacy, directed care, and clearinghouse services, as well as medicare solutions. It also provides patient management services comprising claims management, case management, nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management, and auto claims management. The company provides its services to insurance companies, third-party administrators, employers, and government agencies. CorVel Corporation was founded in 1987 and is based in Irvine, California..
Symmetricom Inc (NASDAQ:SYMM) - Symmetricom, Inc. provides timekeeping technologies, instruments, and solutions worldwide. It offers timekeeping in GPS satellites, national time references, and national power grids, as well as critical military and civilian networks that enable data, voice, mobile and video networks, and services. The company operates in two segments, Communications, and Government and Enterprise. The Communications segment provides timing technologies and services for communications infrastructure. It offers primary reference sources; edge clocks and distribution products for synchronization outside the network core; Building Integrated Timing Supply and Sync Supply unit for the central office; the PackeTime product suite; Synchronous Ethernet; Data Over Cable Service Interface Specifications timing interface systems; network management and monitoring software; and embedded hardware and software solutions for integration with various elements of the communications ecosystem, such as silicon, routers, switches, microwave backhaul, and base stations. The Government and Enterprise segment provides time technology products comprising timescale clock sources; network time servers; network time displays; time code generators; bus level timing cards; primary reference standards, which include cesium oscillator standards; high stability masers; chip-scale atomic clocks; ruggedized crystal oscillators; and custom time and frequency systems. The company sells its products through sales force, distributors, systems integrators, and manufacturer sales representatives, as well as telesales and Internet. Symmetricom, Inc. serves communications service providers; network equipment manufacturers of wireless base stations, routers, and aggregation systems; silicon suppliers; space/defense/avionics; power utility infrastructure; IT infrastructure; underwater exploration and navigation; and science and metrology markets. The company was founded in 1956 and is headquartered in San Jose, California..
DARA Biosciences Inc (NASDAQ:DARA) - DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. Its products include Soltamox for the treatment of breast cancer; Gemcitabine for first-line therapy for ovarian, breast, lung and pancreatic cancers; and other cancer support therapeutics, as well as generic sterile injectable cytotoxic products. Its drug development programs include KRN5500, a non-narcotic/non-opioid that has completed Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959, which has completed a Phase I study for the treatment of metabolic diseases, including type 2 diabetes and dyslipidemia. The company s pre-clinical drug candidate includes DB900 PPAR gamma/alpha/delta agonists for development in metabolic and inflammatory diseases; DB160, DPPIV enzyme inhibitors with applications in diabetes, stem cell transplantation, and cancer therapy; and DB200, Carnitine palmitoyltransferase-1 for skin diseases, including psoriasis. DARA BioSciences, Inc. was incorporated in 2002 and is headquartered in Raleigh, North Carolina..
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Thomas Ronk, CEO
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to firstname.lastname@example.org.
[ Back To Insurance Technology's Homepage ]